AFP and hepatocellular carcinoma: The proportion of HCC cases diagnosed at an early-stage (BCLC 0-A) was 38.0% for no surveillance, which increased to 63.2% for universal US + AFP, 63.8% for risk-stratified surveillance, and 67.6% for precision surveillance.